Professor of Ophthalmology, Harvard Medical School
Ophthalmology
Dr. Evangelos S. Gragoudas, MD
|
|
Give Review
Doctor Evangelos S. Gragoudas, MD works in the field of Ophthalmology. He has 1 awards "Fellow (FAAO)". Evangelos Gragoudas is a published doctor and has 59 publications published. The lastest was: 'Long-term Risk of Melanoma-Related Mortality After Uveal Melanoma-Reply.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Visual Outcomes after Proton Beam Irradiation for Choroidal Melanomas Involving the Fovea.
- Outcomes of proton therapy for the treatment of uveal metastases.
- Effects of metformin on retinoblastoma growth in vitro and in vivo.
- Immunohistochemical investigations of adult intraOcular medulloepitheliomas.
- Proton beam irradiation for non-AMD CNV: 2-year results of a randomised clinical trial.
- The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation.
- Biopsy of an Anterior Episcleral Nodule as an Aid in Managing a Ciliary Body Melanocytic Tumor.
- Aminoimidazole carboxamide ribonucleotide (AICAR) inhibits the growth of retinoblastoma in vivo by decreasing angiogenesis and inducing apoptosis.
- High throughput mass spectrometry-based mutation profiling of primary uveal Melanoma.
- Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families.
- Proton irradiation for peripapillary and parapapillary Melanomas.
- Uveal Melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation.
- Utilizing Targeted Gene Therapy with Nanoparticles Binding Alpha v Beta 3 for Imaging and Treating Choroidal Neovascularization.
- Mortality after diagnosis of small melanocytic lesions of the Choroid.
- Natural history of radiation papillopathy after proton beam irradiation of parapapillary Melanoma.
- Survival in patients with presymptomatic diagnosis of metastatic uveal Melanoma.
- Adjuvant interferon therapy for patients with uveal Melanoma at high risk of metastasis.
- Role of alpha 4 integrin (CD49d) in the pathogenesis of Diabetic retinopathy.
- Ocular melanocytoma.
- Photoreceptor protection after photodynamic therapy using dexamethasone in a rat model of Choroidal neovascularization.
- Vascular adhesion protein-1 blockade suppresses Choroidal neovascularization.
- Increased Choroidal neovascularization following laser induction in mice lacking lysyl oxidase-like 1.
- In vivo imaging of endothelial injury in choriocapillaris during endotoxin-induced uveitis.
- Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveitis.
- Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early Diabetic blood-retinal barrier breakdown.
- Endogenous endostatin inhibits Choroidal neovascularization.
- Photodynamic therapy induces caspase-dependent apoptosis in rat CNV model.
- Inhibition of Hsp90 attenuates inflammation in endotoxin-induced uveitis.
- Reduced photoreceptor damage after photodynamic therapy through blockade of nitric oxide synthase in a model of Choroidal neovascularization.
- Proton beam irradiation for Neovascular age-related macular degeneration.
- Proton beam irradiation of uveal Melanomas: the first 30 years. The Weisenfeld Lecture.
- Investigating the effect of ciliary body photodynamic therapy in a Glaucoma mouse model.
- Histologic correlation of in vivo Optical coherence tomography images of the human retina.
- Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of Choroidal neovascularization.
- Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal Melanoma.
- Melanocytoma of the Optic nerve associated with sound-induced phosphenes.
- Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and Choroid.
- Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental Choroidal neovascularization in the monkey.
- Uveal Melanoma: proton beam irradiation.
- An antisense oligodeoxynucleotide against vascular endothelial growth factor in a nonhuman primate model of iris Neovascularization.
- Treatment of metastatic tumors of the Choroid with proton beam irradiation.
- Expression of leukocyte adhesion molecules in human subfoveal Choroidal neovascular membranes treated with and without photodynamic therapy.
- MRI of blood volume with superparamagnetic iron in choroidal melanoma treated with thermOtherapy.
- Selective photodynamic therapy by targeted verteporfin delivery to experimental Choroidal neovascularization mediated by a homing peptide to vascular endothelial growt...
- Photosensitizers in photodynamic therapy of Choroidal neovascularization.
- MRI of blood volume with MS 325 in experimental Choroidal melanoma.
- VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal Neovascularization.
- Targeted disruption of the CD18 or ICAM-1 gene inhibits Choroidal neovascularization.
- Treatment of experimental Choroidal melanoma with an Nd:yttrium-lanthanum-fluoride laser at 1047 nm.
- Tumor basal area and metastatic death after proton beam irradiation for Choroidal melanoma.
- Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres.
- High-grade uveal B-cell lymphoma as the initial feature in Richter syndrome.
- Verteporfin photodynamic therapy in the rat model of Choroidal neovascularization: angiographic and histologic characterization.
- Expression of pigment epithelium-derived factor in experimental Choroidal neovascularization.
- Prevention of experimental Choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.
- Localization of rose bengal, aluminum phthalocyanine tetrasulfonate, and chlorin e6 in the rabbit eye.
- Long-term risk of local failure after proton therapy for Choroidal/ciliary body melanoma.
- Long-term Risk of Melanoma-Related Mortality After Uveal Melanoma-Reply.
Schools
University of Athens College of Medicine School of Health Science National amp Kapodistrian
Waltham Hospital
Boston University
Joslin Rsch Lab
Mass Ee Infirm
Procedures Preformed
- Contact Lens Services
- Enucleation of Eye
- Eyelid Surgery
Conditions Treated
- Aphakia and Other Disorders of Lens
- Benign Neoplasm of Choroid
- Benign Neoplasm of Eye
- Blepharitis
- View All
Doctors Specialties
- Ophthalmology
Accepted Insurances
Awards
- Fellow (FAAO)
Education
-
Massachusetts Eye & Ear Infirmary -
Boston University Medical Center -
University of Athens
Hospital
-
Massachusetts General Hospital -
Massachusetts Eye and Ear Infirmary
Drug Facts
| NPI NUMBER | 1598756405 | |
| NPPES Provider LastName | GRAGOUDAS | |
| NPPES Provider FirstName | EVANGELOS | |
| NPPES Provider ZIPCode | 021143002 | |
| NPPES Provider State | MA | |
| Specialty Description | Ophthalmology | |
| Total Claim Count | 17.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1598756405 |
| Last Name Of The Provider | GRAGOUDAS |
| First Name Of The Provider | EVANGELOS |
| View All |
Similar Doctors
|
|
Dr. Tasha Y. Tanhehco, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Seanna R. Grob, MD |
|
|
Dr. Scott M. Barb, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lloyd M. Aiello, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. A R. Bellows, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James R. Townley III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicole R. Benitah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher M. Andreoli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deborah K. Vanderveen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Diaz, MD |
|
|
Dr. Caroline Marten-Ellis, MD |
|
|
Dr. John Y. Chen, MD |